MedCity Pivot

For today’s episode, I interviewed Miruna Sasu about Real World Evidence and how that is changing the world of drug development and clinical trials. Who’s The Guest? Miruna Sasu, PhD, MBA is the President and CEO of COTA. She has more than 20 years of experience at leading life science organizations such as Johnson & Johnson and Bristol-Myers Squibb. She also has both a Ph.D. in biology and statistics and a master’s in business administration. Miruna is an accomplished executive with a track record of success when it comes to driving broad-based digital innovation. She brings her deep experience in the utilization and scaling of emerging innovations to advance drug portfolios. Episode Sponsored By Gilead Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Miruna Sasu https://cotahealthcare.com/ ​​https://www.linkedin.com/in/miruna-sasu-7198a113     Review, Subscribe and Share If you like what you hear please leave a review by clicking here Make sure you’re subscribed to the podcast so you get the latest episodes. Click here to subscribe with Apple Podcasts Click here to subscribe with Spotify Click here to subscribe with Podbean Click here to subscribe with RSS

For today’s episode, I interviewed Sonia Millsom to talk about the trends in the healthcare executive search market. We also discuss the progress that has been made in terms of the diversity in the leadership roles in healthcare organizations, and the tension that exists between the desire for experienced executives and the lack of women and people of color in those roles. Who’s The Guest? Sonia Millsom is a veteran healthcare leader. With expensive experience in growing mission-driven innovative healthcare companies, she is passionate about driving change in healthcare to improve people’s access to quality care. Currently, Sonia is the Chief Executive Officer at Oxeon, a trusted healthcare firm powering change through talent, entrepreneurship, and investments. Episode Sponsored By Gilead Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Sonia Millsom ​​https://www.oxeon.com/      https://www.linkedin.com/company/oxeon  https://www.linkedin.com/in/sonia-millsom-a1b993a   Review, Subscribe and Share If you like what you hear please leave a review by clicking here Make sure you’re subscribed to the podcast so you get the latest episodes. Click here to subscribe with Apple Podcasts Click here to subscribe with Spotify Click here to subscribe with Podbean Click here to subscribe with RSS

For today’s episode, I interviewed Anu Osinusi, Vice President of Clinical Research for Hepatitis, Respiratory and Emerging Viruses at Gilead. She talks about how Gilead is at the forefront of battling viral diseases as well as the solutions they are formulating to ensure that each and every person has access to treatments for future pandemics and to preserve global health across the globe. Who’s The Guest? Anu Osinusi serves as the Vice President of Clinical Development at Gilead Sciences. As a clinician-researcher with more than 15 years of experience in drug development, liver diseases, infectious diseases, and global health, she is responsible for overseeing the Viral Hepatitis (Hep B, C, and D), Respiratory and Emerging (COVID-19, Ebola, RSV, and others) Viruses portfolio. Episode Sponsored By Gilead Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Anu Osinusi https://www.gilead.com/  https://www.linkedin.com/in/anu-osinusi-aoo   Review, Subscribe and Share If you like what you hear please leave a review by clicking here Make sure you’re subscribed to the podcast so you get the latest episodes. Click here to subscribe with Apple Podcasts Click here to subscribe with Spotify Click here to subscribe with Podbean Click here to subscribe with RSS

Daniel Perez is the CEO of Hinge Health. Hinge Health is pioneering the world’s most patient-centered Digital Musculoskeletal (MSK) Clinic. They reduce MSK pain, opioid use, and surgeries by pairing advanced wearable technology with a comprehensive clinical care team, including doctors of physical therapy, physicians, board-certified health coaches, and more. Summary I interviewed Dan Perez, CEO of Hinge Health about the value of digital health technologies and how they can lower healthcare costs.   Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Dan Perez https://www.linkedin.com/in/danielperez1 https://twitter.com/danperez610 https://www.hingehealth.com/ https://www.linkedin.com/company/hinge-health 

I interviewed Renee Ryan, CEO of Cala Health, and discussed how a new generation of wearables can address neurological disorders like essential tremors. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Renee Ryan https://highwirepr.com/ https://www.linkedin.com/in/renee-ryan-251b161 

I interviewed Kevin Dedner and spoke about how to achieve cultural humility when delivering care for BIPOC people. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Kevin Dedner https://www.hurdle.health/ https://www.linkedin.com/in/kevin-dedner-mph- 

Michelle Davey, Co-Founder and CEO of Wheel, discusses making virtual care more accessible for patients and clinicians. Topics include virtual first care, clinician burnout due to clunky digital health technologies, addressing burnout and optimizing virtual care delivery, and Wheel's milestones and vision for virtual-first healthcare.

In this episode, Ido Schoenberg, CEO of Amwell, discusses redefining care delivery through virtual care, the challenges of nationwide telehealth adoption, the impact of state licenses on access to healthcare, convincing doctors to embrace telehealth, and the discrepancy between Amwell's positive feedback from clients and their declining stock price.

I interviewed Mike Alkire, CEO of Premier, and discussed how important it is for health systems to achieve scale. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Mike Alkire https://premierinc.com/ https://www.premierinc.com/about/our-people/michael-alkire?section=leadership https://www.linkedin.com/in/michaelalkire 

I spoke with the Chief Medical Officer of Buoy Health, Adrienne McFadden, about how the company has evolved from a symptom checker to a decision support and navigation company. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Adrienne McFadden https://www.buoyhealth.com/ https://www.linkedin.com/company/buoyhealth